Quick Answer
INSMED Inc reported Research And Development Expense of $771.09 million for the year ending 2025.
- INSMED Inc showed an increase of +28.9% in Research And Development Expense from 2024 to 2025.
- This data is from INSMED Inc's annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2010: $769.0 thousand | Q1 2011: $5.76 million | Q2 2011: $8.71 million | Q3 2011: $6.93 million | Q1 2012: $4.74 million | Q2 2012: $7.75 million | Q3 2012: $5.71 million | Q1 2013: $10.33 million | Q2 2013: $12.23 million | Q3 2013: $12.10 million | Q1 2014: $11.35 million | Q2 2014: $14.94 million | Q3 2014: $15.20 million | Q1 2015: $17.16 million | Q2 2015: $18.25 million | Q3 2015: $19.22 million | Q1 2016: $20.55 million | Q2 2016: $23.87 million | Q3 2016: $23.43 million | Q1 2017: $22.25 million | Q2 2017: $26.87 million | Q3 2017: $26.68 million | Q1 2018: $30.10 million | Q2 2018: $35.72 million | Q3 2018: $39.54 million | Q1 2019: $31.20 million | Q2 2019: $33.54 million | Q3 2019: $34.34 million | Q1 2020: $36.18 million | Q2 2020: $35.75 million | Q3 2020: $41.41 million | Q1 2021: $61.39 million | Q2 2021: $64.66 million | Q3 2021: $70.35 million | Q1 2022: $84.36 million | Q2 2022: $88.53 million | Q3 2022: $99.87 million | Q1 2023: $127.87 million | Q2 2023: $196.97 million | Q3 2023: $109.15 million | Q1 2024: $121.08 million | Q2 2024: $146.75 million | Q3 2024: $150.81 million | Q1 2025: $152.58 million | Q2 2025: $177.19 million | Q3 2025: $186.42 million.
- Over the full 17 years of available data (2009 to 2025), INSMED Inc's Research And Development Expense has grown by 8,275.1%.
- Historical annual values: Fiscal year 2025: $771.09 million | Fiscal year 2024: $598.37 million | Fiscal year 2023: $571.01 million | Fiscal year 2022: $397.52 million | Fiscal year 2021: $272.74 million | Fiscal year 2020: $181.16 million | Fiscal year 2019: $131.71 million | Fiscal year 2018: $145.28 million | Fiscal year 2017: $109.75 million | Fiscal year 2016: $122.72 million | Fiscal year 2015: $74.28 million | Fiscal year 2014: $56.29 million | Fiscal year 2013: $44.28 million | Fiscal year 2012: $29.78 million | Fiscal year 2011: $28.62 million | Fiscal year 2010: $4.70 million | Fiscal year 2009: $9.21 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: